Clinical Trial Update: A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event [Phase 3]

View source ↗

Summary

A Phase III study of AZD0780 to evaluate major adverse cardiovascular events in patients with a history of ASCVD or at high risk for a first event is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease

Drugs mentioned

• AZD0780

Snippet

Sponsor: AstraZeneca | Conditions: Cardiovascular Disease | Phase 3 | Status: RECRUITING